(Q38064740)

28 August 2017

1 reference

title

Biomarkers in early-stage colorectal cancer: ready for prime time? (English)

1 reference

28 August 2017

0 references

1 reference

1 reference

David Kerr

3

1 reference

ORCID Public Data File 2021

author name string

David Church

series ordinal

1

1 reference

PubMed ID

23207929

28 August 2017

Rachel Midgley

series ordinal

2

1 reference

28 August 2017

23 November 2012

1 reference

28 August 2017

1 reference

28 August 2017

30 Suppl 2

1 reference

28 August 2017

27-33

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

28 August 2017

1 reference

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

21 January 2018

1 reference

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

21 January 2018

1 reference

The emergence of 'omics for the management of colorectal cancer

21 January 2018

1 reference

Systematic review of genetic influences on the prognosis of colorectal cancer

21 January 2018

1 reference

Use of archived specimens in evaluation of prognostic and predictive biomarkers

21 January 2018

1 reference

Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis

21 January 2018

1 reference

Chromosomal instability confers intrinsic multidrug resistance.

21 January 2018

1 reference

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis

21 January 2018

1 reference

Targeting RAS signalling pathways in cancer therapy

21 January 2018

1 reference

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

21 January 2018

1 reference

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

21 January 2018

1 reference

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

21 January 2018

1 reference

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

21 January 2018

1 reference

Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

21 January 2018

1 reference

RAF/RAS oncogenes and mismatch-repair status

21 January 2018

1 reference

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

21 January 2018

1 reference

Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor

21 January 2018

1 reference

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study

21 January 2018

1 reference

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.

21 January 2018

1 reference

DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.

21 January 2018

1 reference

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer

21 January 2018

1 reference

Systematic review of microsatellite instability and colorectal cancer prognosis

21 January 2018

1 reference

Mismatch repair proficiency and in vitro response to 5-fluorouracil

21 January 2018

1 reference

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer

21 January 2018

1 reference

Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data

21 January 2018

1 reference

Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.

21 January 2018

1 reference

Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

21 January 2018

1 reference

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer

21 January 2018

1 reference

Molecular staging for survival prediction of colorectal cancer patients

21 January 2018

1 reference

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

21 January 2018

1 reference

Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000341890

1 reference

28 August 2017

1 reference

PubMed ID

23207929